Women's Health Initiative is a partially blinded, controlled clinical trial in postmenopausal women. The trial will evaluate the benefits and risks of hormone replacement therapy (HRT), dietary modification (DM), and supplementation with calcium/vitamin D (CaD) on the overall health of postmenopausal women. Health will be assessed on the basis of quality of life measurements, cause specific morbidity and mortality, and total mortality.
Showing the most recent 10 out of 859 publications